Syndromic Surveillance-Based Estimates of Vaccine Efficacy Against COVID-Like Illness from Emerging Omicron and COVID-19 Variants

Tanner J. Varrelman, Benjamin Rader, Christina M. Astley, John S. Brownstein
doi: https://doi.org/10.1101/2021.12.17.21267995

Article Information

doi 
https://doi.org/10.1101/2021.12.17.21267995
History 
  • December 18, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Tanner J. Varrelman1,*,
  2. Benjamin Rader1,2,
  3. Christina M. Astley3,1,4,5 and
  4. John S. Brownstein1,4
  1. 1Computational Epidemiology Lab, Boston Children’s Hospital, Boston, MA 02115
  2. 2Department of Epidemiology, Boston University, Boston, MA 02118
  3. 3Division of Endocrinology, Boston Children’s Hospital, Boston, MA 02115
  4. 4Harvard Medical School, Boston, MA 02115
  5. 5Broad Institute of Harvard and MIT, Cambridge, MA 02142
  1. ↵*Corresponding author; email: tanner.varrelman{at}childrens.harvard.edu
Back to top
Posted December 18, 2021.
Download PDF
Data/Code
Email
Syndromic Surveillance-Based Estimates of Vaccine Efficacy Against COVID-Like Illness from Emerging Omicron and COVID-19 Variants
Tanner J. Varrelman, Benjamin Rader, Christina M. Astley, John S. Brownstein
medRxiv 2021.12.17.21267995; doi: https://doi.org/10.1101/2021.12.17.21267995
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area